Related references
Note: Only part of the references are listed.The heightened importance of the microbiome in cancer immunotherapy
Clelia Villemin et al.
TRENDS IN IMMUNOLOGY (2023)
Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles
Ruyi Wang et al.
NATURE BIOMEDICAL ENGINEERING (2023)
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity
Kebria Hezaveh et al.
IMMUNITY (2022)
A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota
Meriem Messaoudene et al.
CANCER DISCOVERY (2022)
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
Hai Wang et al.
CELL METABOLISM (2022)
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Melody Smith et al.
NATURE MEDICINE (2022)
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park et al.
NATURE MEDICINE (2022)
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Jorge Luis Galeano Nino et al.
NATURE (2022)
Immune checkpoint therapy: Forging ahead
Padmanee Sharma et al.
Science Translational Medicine (2022)
Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy
Priya Rangan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors
Anders B. Dohlman et al.
CELL (2022)
Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome
Lianmin Chen et al.
NATURE MEDICINE (2022)
Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling
Barath Udayasuryan et al.
SCIENCE SIGNALING (2022)
Lactate increases stemness of CD8+T cells to augment anti-tumor immunity
Qiang Feng et al.
NATURE COMMUNICATIONS (2022)
The gut microbial metabolite formate exacerbates colorectal cancer progression
Dominik Ternes et al.
NATURE METABOLISM (2022)
Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics
Kentaro Inamura
SEMINARS IN CANCER BIOLOGY (2021)
Gut microbiota in human metabolic health and disease
Yong Fan et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Gut microbiota-derived metabolites as central regulators in metabolic disorders
Allison Agus et al.
GUT (2021)
Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells
Amina Iftekhar et al.
NATURE COMMUNICATIONS (2021)
Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation
Travis T. Sims et al.
COMMUNICATIONS BIOLOGY (2021)
Molecules from the Microbiome
Emilee E. Shine et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 90, 2021 (2021)
Tumour neoantigen mimicry by microbial species in cancer immunotherapy
Maximilian Boesch et al.
BRITISH JOURNAL OF CANCER (2021)
Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
Yao He et al.
CELL METABOLISM (2021)
Emerging concepts in the science of vaccine adjuvants
Bali Pulendran et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
The microbiome and human cancer
Gregory D. Sepich-Poore et al.
SCIENCE (2021)
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano et al.
CANCER DISCOVERY (2021)
Microbial metabolites: novel therapeutic tools for boosting cancer therapies
Maik Luu et al.
TRENDS IN CELL BIOLOGY (2021)
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Maik Luu et al.
NATURE COMMUNICATIONS (2021)
The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data
Dong Yu et al.
FRONTIERS IN ONCOLOGY (2021)
The Role of Short-Chain Fatty Acids and Bile Acids in Intestinal and Liver Function, Inflammation, and Carcinogenesis
Alexander Visekruna et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Roles of microbiota in response to cancer immunotherapy
Kentaro Inamura
SEMINARS IN CANCER BIOLOGY (2020)
Microbiota Metabolites in Health and Disease
Justin L. McCarville et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman et al.
SCIENCE (2020)
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
Clelia Coutzac et al.
NATURE COMMUNICATIONS (2020)
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
Clarissa Campbell et al.
NATURE (2020)
Colibactin DNA-damage signature indicates mutational impact in colorectal cancer
Paulina J. Dziubanska-Kusibab et al.
NATURE MEDICINE (2020)
Co-evolution and Co-speciation of Host-Gut Bacteria Systems
Mathieu Groussin et al.
CELL HOST & MICROBE (2020)
The Gut Microbiota at the Service of Immunometabolism
Chloe Michaudel et al.
CELL METABOLISM (2020)
Inosine: novel microbiota-derived immunostimulatory metabolite
Guido Kroemer et al.
CELL RESEARCH (2020)
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager et al.
SCIENCE (2020)
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression
Lishay Parhi et al.
NATURE COMMUNICATIONS (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Chengcheng Jin et al.
CELL (2019)
Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1
Mara Roxana Rubinstein et al.
EMBO REPORTS (2019)
A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult
Ziad Al Nabhani et al.
IMMUNITY (2019)
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Takeshi Tanoue et al.
NATURE (2019)
The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes
Maik Luu et al.
NATURE COMMUNICATIONS (2019)
Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells
Maik Luu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
The microbiota and microbiome in pancreatic cancer: more influential than expected
Miao-Yan Wei et al.
MOLECULAR CANCER (2019)
Acetate Promotes T Cell Effector Function during Glucose Restriction
Jing Qiu et al.
CELL REPORTS (2019)
Exploring the emerging role of the microbiome in cancer immunotherapy
Jessica Fessler et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
A. Elkrief et al.
ANNALS OF ONCOLOGY (2019)
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
Shinichi Yachida et al.
NATURE MEDICINE (2019)
Laboratory mice born to wild mice have natural microbiota and model human immune responses
Stephan P. Rosshart et al.
SCIENCE (2019)
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Erick Riquelme et al.
CELL (2019)
Microbes as biomarkers and targets in pancreatic cancer
Joshua C. Leinwand et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL
Berk Aykut et al.
NATURE (2019)
The intimate relationship between gut microbiota and cancer immunotherapy
Arielle Elkrief et al.
GUT MICROBES (2019)
Mining the microbiota for microbial and metabolite-based immunotherapies
Ashwin N. Skelly et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Harnessing the Microbiome for Pancreatic Cancer Immunotherapy
Gerardo A. Vitiello et al.
TRENDS IN CANCER (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Vancheswaran Gopalakrishnan et al.
CANCER CELL (2018)
Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models
Ryan M. Thomas et al.
CARCINOGENESIS (2018)
The gut microbiota influences anticancer immunosurveillance and general health
Bertrand Routy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Laurence Zitvogel et al.
SCIENCE (2018)
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Smruti Pushalkar et al.
CANCER DISCOVERY (2018)
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance
Stephan P. Rosshart et al.
CELL (2017)
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
TaChung Yu et al.
CELL (2017)
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes
Eliana Marino et al.
NATURE IMMUNOLOGY (2017)
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Ara Koh et al.
CELL (2016)
Gut Microbial Metabolites Fuel Host Antibody Responses
Myunghoo Kim et al.
CELL HOST & MICROBE (2016)
Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans
Elko Randrianarisoa et al.
SCIENTIFIC REPORTS (2016)
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis
Constantinos P. Zambirinis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Emerging cytokine networks in colorectal cancer
Nathan R. West et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real?
Ryan M. Thomas et al.
TRENDS IN CANCER (2015)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation
Chang H. Kim et al.
Immune Network (2014)
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar D. Kostic et al.
CELL HOST & MICROBE (2013)
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
Mara Roxana Rubinstein et al.
CELL HOST & MICROBE (2013)
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
Gijs den Besten et al.
JOURNAL OF LIPID RESEARCH (2013)
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Nicholas Arpaia et al.
NATURE (2013)
Microbiota, Disease, and Back to Health: A Metastable Journey
Richard Blumberg et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota
June L. Round et al.
SCIENCE (2011)
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota
June L. Round et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer
Nathaniel S. Rial et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Regulatory T cells and intestinal homeostasis
JL Coombes et al.
IMMUNOLOGICAL REVIEWS (2005)
Share Paper
